Santillán-Hernández Yuritzi, Almanza-Miranda Enory, Xin Winnie W, Goss Kendrick, Vera-Loaiza Aurea, Gorráez-de la Mora María T, Piña-Aguilar Raul E
Yuritzi Santillán-Hernández, Aurea Vera-Loaiza, Medical Genetics Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, México City 03100, México.
World J Gastroenterol. 2015 Jan 21;21(3):1001-8. doi: 10.3748/wjg.v21.i3.1001.
Lysosomal acid lipase (LAL) deficiency is an under-recognized lysosomal disease caused by deficient enzymatic activity of LAL. In this report we describe two affected female Mexican siblings with early hepatic complications. At two months of age, the first sibling presented with alternating episodes of diarrhea and constipation, and later with hepatomegaly, elevated transaminases, high levels of total and low-density lipoprotein cholesterol, and low levels of high-density lipoprotein. Portal hypertension and grade 2 esophageal varices were detected at four years of age. The second sibling presented with hepatomegaly, elevated transaminases and mildly elevated low-density lipoprotein and low high-density lipoprotein at six months of age. LAL activity was deficient in both patients. Sequencing of LIPA revealed two previously unreported heterozygous mutations in exon 4: c.253C>A and c.294C>G. These cases highlight the clinical continuum between the so-called Wolman disease and cholesteryl ester storage disease, and underscore that LAL deficiency represents a single disease with a degree of clinical heterogeneity.
溶酶体酸性脂肪酶(LAL)缺乏症是一种因LAL酶活性不足而未被充分认识的溶酶体疾病。在本报告中,我们描述了两名患有早期肝脏并发症的墨西哥患病女性同胞。第一名同胞在两个月大时出现腹泻和便秘交替发作,随后出现肝肿大、转氨酶升高、总胆固醇和低密度脂蛋白胆固醇水平升高以及高密度脂蛋白水平降低。四岁时检测到门静脉高压和2级食管静脉曲张。第二名同胞在六个月大时出现肝肿大、转氨酶升高以及低密度脂蛋白轻度升高和高密度脂蛋白降低。两名患者的LAL活性均不足。LIPA测序显示外显子4中有两个先前未报道的杂合突变:c.253C>A和c.294C>G。这些病例突出了所谓的沃尔曼病和胆固醇酯贮积病之间的临床连续性,并强调LAL缺乏症代表一种具有一定临床异质性的单一疾病。